A strategy for multimodal data integration: application to biomarkers identification in spinocerebellar ataxia
Abstract
The growing number of modalities (e.g. multi-omics, imaging and clinical data) characterizing a given disease provides physicians and statisticians with complementary facets reflecting the disease process but emphasizes the need for novel statistical methods of data analysis able to unify these views. Such data sets are indeed intrinsically structured in blocks, where each block represents a set of variables observed on a group of individuals. Therefore, classical statistical tools cannot be applied without altering their organization, with the risk of information loss. Regularized generalized canonical correlation analysis (RGCCA) and its sparse generalized canonical correlation analysis (SGCCA) counterpart are component-based methods for exploratory analyses of data sets structured in blocks of variables. Rather than operating sequentially on parts of the measurements, the RGCCA/SGCCA-based integrative analysis method aims at summarizing the relevant information between and within the blocks. It processes a priori information defining which blocks are supposed to be linked to one another, thus reflecting hypotheses about the biology underlying the data blocks. It also requires the setting of extra parameters that need to be carefully adjusted.Here, we provide practical guidelines for the use of RGCCA/SGCCA. We also illustrate the flexibility and usefulness of RGCCA/SGCCA on a unique cohort of patients with four genetic subtypes of spinocerebellar ataxia, in which we obtained multiple data sets from brain volumetry and magnetic resonance spectroscopy, and metabolomic and lipidomic analyses. As a first step toward the extraction of multimodal biomarkers, and through the reduction to a few meaningful components and the visualization of relevant variables, we identified possible markers of disease progression.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Multi-omics machine learning is still at an early stage, yet it has been explored across many application areas.
“Although ML analysis of multi-omics is still in its embryonic stage, it has already been explored for a wide range of applications, as reported in recent reviews on brain diseases (Garali et al., 2018;Young et al., 2013), diabetes (Kavakiotis et al., 2017), cancers (Borad and LoRusso, 2017;Chaudhary et al., 2017;Wong et al., 2016) cardiovascular disease (Weng et al., 2017), medical imaging (Ericks”
From Using machine learning approaches for multi-omics data analysis: A review (2021) · cites this paper as Garali et al., 2018
The citation lists haven’t been fetched yet
References 60 · Cited by 68
- Authors
- Garali, I., Adanyeguh, I. M., Ichou, F., Perlbarg, V., Seyer, A., Colsch, B., Moszer, I., Guillemot, V., Durr, A., Mochel, F., & Tenenhaus, A.
- Affiliations
- Bioinformatics and Biostatistics Core Facility of the Brain and Spine Institute, La Pitié-Salpêtriére Hospital, Paris, France
- Université Pierre-et-Marie-Curie (FR)
- Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR)
- Pitié-Salpêtrière Hospital (FR)
- MedDay (France) (FR)
- LEMM Laboratory at CEA-Saclay, France
- Institut Pasteur (FR)
- Pitié-Salpêtriére University Hospital in Paris
- Supélec (FR)
- Corresponding author
- Tenenhaus, Arthur
- ORCID
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-03
- Volume
- 19
- Issue
- 6
- Pages
- 1356-1369
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W2728397260
- Cited by
- 68
- References
- 60
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 17 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 5 · 2018: 2 · 2017: 2
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Briefings in Bioinformatics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Assistance-Publique des Hôpitaux de Paris
- French Ministry of Health (2010-A01324-35)
- Cognacq-Jay foundation
- Investissements d’avenir (ANR-10-IAIHU-06)
- patients’ association Connaitre les Syndromes Cérébelleux (CSC)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Physical Sciences › Mathematics › Computational Mathematics › Tensor decomposition and applications
- Keywords
- multimodal data integration, spinocerebellar ataxia, biomarker discovery, multi-omics data, brain volumetry, magnetic resonance spectroscopy, metabolomics, lipidomics, disease progression biomarkers, genetic subtypes
- MeSH terms
- Algorithms, Brain, Humans, Reproducibility of Results, Biomarkers, Case-Control Studies, Guidelines as Topic, Spinocerebellar Ataxias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review